Dilated Cardiomyopathy Overview

Ray E Hershberger; Ana Morales

Dilated Cardiomyopathy Overview

Review

In: GeneReviews^® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020.

2007 Jul 27 [updated 2018 Aug 23].

Authors

Ray E Hershberger¹, Ana Morales²

Book Editors

Margaret P Adam, Holly H Ardinger, Roberta A Pagon, Stephanie E Wallace, Lora JH Bean, Karen Stephens, Anne Amemiya

Affiliations

¹ Professor of Medicine, Divisions of Human Genetics and Cardiovascular Medicine, The Ohio State University, Columbus, Ohio
² Associate Professor, Division of Human Genetics, The Ohio State University, Columbus, Ohio

PMID: 20301486
NBK1309

Excerpt

The purpose of this overview is to increase clinician awareness of the genetic basis of dilated cardiomyopathy (DCM) and the benefits of early diagnosis and management to individuals with genetic DCM. The following are the goals of this overview.

Goal 1: Define DCM.

Goal 2: Identify the categories of DCM.

Goal 3: Provide the evaluation strategy of a proband with nonsyndromic DCM.

Goal 4: Provide a basic view of genetic risk assessment of at-risk asymptomatic relatives of a proband with DCM to inform cardiac surveillance and allow early detection and treatment of DCM to improve long-term outcome.

Sections

Publication types

Review